These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15521484)

  • 1. Gender aspects in heart failure. Pathophysiology and medical therapy.
    Regitz-Zagrosek V; Lehmkuhl E; Lehmkuhl HB; Hetzer R
    Arch Mal Coeur Vaiss; 2004 Sep; 97(9):899-908. PubMed ID: 15521484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart failure and its treatment in women. Role of hypertension, diabetes, and estrogen.
    Regitz-Zagrosek V; Lehmkuhl E
    Herz; 2005 Aug; 30(5):356-67. PubMed ID: 16132238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Heart failure--are there gender aspects?].
    Regitz-Zagrosek V; Lehmkuhl E; Lehmkuhl HB
    Internist (Berl); 2008 Apr; 49(4):422-6, 428. PubMed ID: 18301870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of gender in heart failure with normal left ventricular ejection fraction.
    Regitz-Zagrosek V; Brokat S; Tschope C
    Prog Cardiovasc Dis; 2007; 49(4):241-51. PubMed ID: 17185112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of gender and etiology with outcomes in heart failure with systolic dysfunction: a pooled analysis of 5 randomized control trials.
    Frazier CG; Alexander KP; Newby LK; Anderson S; Iverson E; Packer M; Cohn J; Goldstein S; Douglas PS
    J Am Coll Cardiol; 2007 Apr; 49(13):1450-8. PubMed ID: 17397674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Response to drug therapy of cardiac failure according to gender].
    Juillière Y; Berder V; Brembilla-Perrot B; Selton-Suty C
    Arch Mal Coeur Vaiss; 2004 Dec; 97(12):1216-20. PubMed ID: 15669363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gender differences in pharmacotherapy of chronic heart failure].
    Klabník A; Murín J
    Vnitr Lek; 2009 Dec; 55(12):1167-72. PubMed ID: 20070033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart failure in women.
    Silber DH
    Curr Womens Health Rep; 2003 Apr; 3(2):104-9. PubMed ID: 12628079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of morbidity in women versus men with heart failure and preserved ejection fraction.
    Deswal A; Bozkurt B
    Am J Cardiol; 2006 Apr; 97(8):1228-31. PubMed ID: 16616031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients.
    Vijan SG
    J Indian Med Assoc; 2009 Mar; 107(3):178-82. PubMed ID: 19810392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
    Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
    Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure.
    Dieterich HA; Wendt C; Saborowski F
    Fiziol Cheloveka; 2005; 31(6):97-105. PubMed ID: 16366159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart failure in women.
    Pĩna IL; Buchter C
    Cardiol Rev; 2003; 11(6):337-44. PubMed ID: 14580303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of remodeling in congestive heart failure due to myocardial infarction by blockade of the renin-angiotensin system.
    Guo X; Saini HK; Wang J; Gupta SK; Goyal RK; Dhalla NS
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):717-32. PubMed ID: 16076281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart failure in women: a need for prospective data.
    Hsich EM; Piña IL
    J Am Coll Cardiol; 2009 Aug; 54(6):491-8. PubMed ID: 19643307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gender differences in non-pharmacological treatment of chronic heart failure].
    Klabník A; Murín J; Kycina P
    Vnitr Lek; 2010 May; 56(5):427-33. PubMed ID: 20578593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking the renin-angiotensin system: dual- versus mono-therapy.
    Ravandi A; Teo KK
    Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):667-74. PubMed ID: 19505282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis.
    Balamuthusamy S; Srinivasan L; Verma M; Adigopula S; Jalandhara N; Hathiwala S; Smith E
    Am Heart J; 2008 May; 155(5):791-805. PubMed ID: 18440325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.